80 related articles for article (PubMed ID: 32492707)
1. TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression.
Zhang LH; Yin YH; Chen HZ; Feng SY; Liu JL; Chen L; Fu WL; Sun GC; Yu XG; Xu DG
Neuro Oncol; 2020 Dec; 22(12):1797-1808. PubMed ID: 32492707
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
[TBL] [Abstract][Full Text] [Related]
3. Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXRα neurogenic pathway.
Liu RZ; Choi WS; Jain S; Xu X; Elsherbiny ME; Glubrecht DD; Tessier AG; Easaw JC; Fallone BG; Godbout R
Neuro Oncol; 2023 Dec; 25(12):2177-2190. PubMed ID: 37499046
[TBL] [Abstract][Full Text] [Related]
4. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/ERK signalling axis.
Wang Y; Wang B; Cao W; Xu X
Biochem Biophys Res Commun; 2024 Apr; 703():149665. PubMed ID: 38359612
[TBL] [Abstract][Full Text] [Related]
5. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma.
Pang L; Dunterman M; Guo S; Khan F; Liu Y; Taefi E; Bahrami A; Geula C; Hsu WH; Horbinski C; James CD; Chen P
Nat Immunol; 2023 Oct; 24(10):1654-1670. PubMed ID: 37667051
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the role of transcription factors in glioblastoma cancer stem cells.
Li K; Li H; He A; Zhang G; Jin Y; Cai J; Ye C; Qi L; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2024 May; ():. PubMed ID: 38716541
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Glioblastoma Cell Culture Platforms Based on Transcriptional Similarity with Paired Tissue.
Park J; Koh I; Cha J; Oh Y; Shim JK; Kim H; Moon JH; Kim EH; Chang JH; Kim P; Kang SG
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675489
[TBL] [Abstract][Full Text] [Related]
8. Brain tumors: Cancer stem-like cells interact with tumor microenvironment.
Liu HL; Wang YN; Feng SY
World J Stem Cells; 2020 Dec; 12(12):1439-1454. PubMed ID: 33505594
[TBL] [Abstract][Full Text] [Related]
9. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling.
Wei Y; Lu C; Zhou P; Zhao L; Lyu X; Yin J; Shi Z; You Y
Neuro Oncol; 2021 Apr; 23(4):611-624. PubMed ID: 32926734
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy.
Schnabel E; Knoll M; Schwager C; Warta R; Mock A; Campos B; König L; Jungk C; Wick W; Unterberg A; Debus J; Herold-Mende C; Abdollahi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803955
[TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase TRIM24 deficiency promotes NLRP3/caspase-1/IL-1β-mediated pyroptosis in endometriosis.
Hang Y; Tan L; Chen Q; Liu Q; Jin Y
Cell Biol Int; 2021 Jul; 45(7):1561-1570. PubMed ID: 33724611
[TBL] [Abstract][Full Text] [Related]
12. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
[TBL] [Abstract][Full Text] [Related]
13. Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.
Lopez-Bertoni H; Johnson A; Rui Y; Lal B; Sall S; Malloy M; Coulter JB; Lugo-Fagundo M; Shudir S; Khela H; Caputo C; Green JJ; Laterra J
Signal Transduct Target Ther; 2022 Feb; 7(1):37. PubMed ID: 35136034
[TBL] [Abstract][Full Text] [Related]
14. TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis.
Jeon J; Noh HJ; Lee H; Park HH; Ha YJ; Park SH; Lee H; Kim SJ; Kang HC; Eyun SI; Yang S; Kim YS
Ann Rheum Dis; 2020 Dec; 79(12):1635-1643. PubMed ID: 32895234
[TBL] [Abstract][Full Text] [Related]
15. TIF1 Proteins in Genome Stability and Cancer.
McAvera RM; Crawford LJ
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32731534
[TBL] [Abstract][Full Text] [Related]
16. LncRNA linc01194 promotes the progress of endometrial carcinoma by up-regulating SOX2 through binding to IGF2BP1.
Huang Z; Shen F; Chen J; Xie B; Chen X; Zhao Y; Chen S
J Gynecol Oncol; 2024 Mar; 35(2):e21. PubMed ID: 38072399
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic reprogramming of a distal developmental enhancer cluster drives SOX2 overexpression in breast and lung adenocarcinoma.
Abatti LE; Lado-Fernández P; Huynh L; Collado M; Hoffman MM; Mitchell JA
Nucleic Acids Res; 2023 Oct; 51(19):10109-10131. PubMed ID: 37738673
[TBL] [Abstract][Full Text] [Related]
18. The role of m6A-modified CircEPHB4 in glioma pathogenesis: Insights into cancer stemness metastasis.
Liao Y; Qiu X; Liu J; Zhang Z; Liu B; Jin C
Ann Clin Transl Neurol; 2023 Oct; 10(10):1749-1767. PubMed ID: 37614011
[TBL] [Abstract][Full Text] [Related]
19. A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis.
Bi Y; Zheng R; Hu J; Shi R; Shi J; Wang Y; Wang P; Jiang W; Kim G; Liu Z; Li X; Lin L
Genes Dis; 2024 Jan; 11(1):479-494. PubMed ID: 37588207
[TBL] [Abstract][Full Text] [Related]
20. Aberrant KAT2A accumulations render TRIM22-low melanoma sensitive to Notch1 inhibitors via epigenetic reprogramming.
Gu X; Min W; Zeng Y; Fan N; Qian Q
J Transl Med; 2023 Jul; 21(1):443. PubMed ID: 37415153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
